961 results on '"Prostatic tumor"'
Search Results
2. Antigrowth effect of polyamine biosynthesis inhibitors on the dunning R 3327-G prostatic tumor.
3. 17α-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
4. Cushing syndrome associated with prostatic tumor adrenocorticotropic hormone (ACTH) expression after maximal androgen blockade therapy.
5. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry.
6. High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer.
7. Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithine.
8. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
9. Potentiation by estramustine of the cytotoxic effect of vinblastine and doxorubicin in prostatic tumor cells.
10. Prostatic tumor implantation in the nude mouse via a perineal approach.
11. Effect of early exposure of flutamide on subsequent growth of transplantable rat prostatic tumor (dunning R-3327).
12. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction.
13. Isolation and characterization of transforming growth factor beta response variants from human prostatic tumor cell lines.
14. Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.
15. Prostatic tumor (R3327) skeletal metastasis.
16. [1, 2-bis (2, 6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloro-platinum(II): An endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity.
17. Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.
18. Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration.
19. Expression of p21 and mutant p53 gene products in residual prostatic tumor cells after radical radiotherapy.
20. Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases.
21. In vitro radiation sensitivity of the lncap prostatic tumor cell line.
22. Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells.
23. The in vivo effect of regional hyperthermia on dunning R3327 prostatic tumor.
24. Hypoxia‐inducible factor 1A inhibition overcomes castration resistance of prostate tumors.
25. Nintedanib treatment delays prostate dorsolateral lobe cancer progression in the TRAMP model: contribution to the epithelial‐stromal interaction balance.
26. Tumor‐associated macrophage‐derived CCL5 promotes chemotherapy resistance and metastasis in prostatic cancer.
27. Role of prolactin in modulating the effects of tamoxifen on growth of the dunning R3327 rat prostate adenocarcinoma.
28. Addressing Apoptosis to Tumor Zip Codes.
29. Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor‐Associated Macrophages in Prostate Cancer.
30. Inflammatory myofibroblastic tumor of the prostate.
31. Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients.
32. Clinical outcomes in patients with metastatic castrate‐resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case–control study.
33. Melatonin: Avenues in cancer therapy and its nanotechnological advancements.
34. A new hybrid quantitative structure property relationships‐support vector regression (QSPR‐SVR) approach for predicting the solubility of drug compounds in supercritical carbon dioxide.
35. Inflammatory responses during trichomoniasis: The role of Toll‐like receptors and inflammasomes.
36. Potentiation of methylglyoxal-bis-guanylhydrazone by alpha-difluoromethylornithine in rat prostate cancer.
37. Apoptosis in rat prostatic adenocarcinoma is associated with rapid infiltration of cytotoxic T-cells and activated macrophages.
38. Effect of early treatment of prostate cancer with the 5α-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats.
39. Effect of turosteride, a 5α-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.
40. Androgen receptor status of lymph node metastases from prostate cancer.
41. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma.
42. Cytochemical localization of lipid, peroxidase, and carbohydrate substances in the dunning prostatic adenocarcinoma R3327H: An ultrastructural analysis.
43. Resistance to prostate cancer treatments.
44. Sodium channels and the ionic microenvironment of breast tumours.
45. Cofilin promotes vasculogenic mimicry by regulating the actin cytoskeleton in human breast cancer cells.
46. circEZH2E2/E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression.
47. Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium.
48. Proteoglycans orchestrate remodeling of prostatic cytoarchitecture after androgenic blockade in old gerbils.
49. Proteoglycans orchestrate remodeling of prostatic cytoarchitecture after androgenic blockade in old gerbils.
50. Intra-Arterial Chemotherapy Infusion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.